Public dataset
Recorded source agreement and disagreement
Show whether sources print one normalized reading, have incompatible units, lack structured comparison context, or contain a context-matched numeric difference.
- Public rows
- 1,681
- Generated
- Schema version
- source-consensus/2
Coverage
What this run contains
- Compared medicine fields
- 1,681
- Agree
- 1,282
- Differ
- 0
- Not comparable
- 12
- Insufficient context
- 387
- Fields represented
- 5
- bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
Method
How the rows were made
- Deterministic rules normalize recorded pharmacokinetic readings and compare only like-for-like values.
- One normalized printed reading may be agree even when clinical context was not extracted; this reports printed-reading agreement only.
- Distinct readings may differ only when their units and denominators are comparable and one matching, non-placeholder population/formulation context was structurally extracted. Otherwise they are insufficient_context.
- not_comparable preserves incompatible units or denominators instead of guessing. insufficient_context preserves missing or non-matching structured context instead of manufacturing agreement or disagreement.
- The agreement rate describes the distribution of recorded source readings; it is not a probability that a value is true.
- Every distinct printed reading retains its unit, population context, source count, and complete source records. The API paginates field rows, never child readings or sources.
- documentsExamined is every matching single-substance archive document inspected for that medicine. The generator has no document, reading, or source ceiling, so there is no hidden available-versus-retained remainder.
Limits
Read these before using a row
- Current label parsing does not structurally extract population or formulation context. Distinct otherwise-comparable readings are therefore insufficient_context, never differ; agree may mean printed-reading agreement only. Source records are complete but are not independent-experiment counts.
- The current deterministic parser does not structurally extract population or formulation context from these sentences. It records that context as unknown and cannot publish distinct same-unit readings as differ.
- Neither reading is marked wrong. Population, formulation, route, and other unextracted context may explain the printed difference.
- Only the recorded fields and source documents in this snapshot are compared.
- A source count is the number of retained source records in the row, not a count of independent experiments.
Provenance
Source examples
abacavir · bioavailability · agree
15 documents examined; 83% (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:5676d391-f9a4-44be-9604-954b3d8d0e2b (opens source in a new tab)The geometric mean absolute bioavailability of the tablet was 83%.
alemtuzumab · volumeOfDistribution · not_comparable
2 documents examined; 0.18 L/kg (Unknown: population and formulation context were not structurally extracted from this source sentence.); 14.1 L (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:4f5f7255-7abc-4328-bd1a-ceaf139ef3e0 (opens source in a new tab)Distribution After the last 30 mg dose, the mean volume of distribution at steady-state was 0.18 L/kg (range 0.1 to 0.4 L/kg).
abiraterone · halfLife · insufficient_context
31 documents examined; 12 ± 5 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.); 18 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:c9eb9b46-f847-40a8-802c-a51b40406d5a (opens source in a new tab)Elimination In patients with metastatic CRPC, the mean terminal half-life of abiraterone in plasma (mean ± SD) is 12 ± 5 hours.
Artifact used for this view: data/source-consensus.ndjson. The reader resolves the current run first and uses the checked-in compatibility run only when a current artifact is absent.
Schema
Fields in the public projection
| Field | Type | Meaning |
|---|---|---|
| medicineSlug | string | Stable RNAWiki medicine route key. |
| field | string | Recorded pharmacokinetic field being compared. |
| comparisonState | string | agree (printed-reading agreement), differ (context-matched comparable disjoint values), not_comparable (unit/denominator mismatch), or insufficient_context. Every state remains declared even when its current count is zero. |
| comparisonReasons | string[] | Deterministic codes explaining the state. |
| documentsExamined | number | Recorded source documents considered for the field. |
| sourceCount | number | Recorded source readings represented. |
| agreementRate | number | Share represented by the leading normalized printed-reading group; not a confidence score or clinical agreement probability. |
| readings | consensus-reading[] | Complete, untruncated reading groups. Each keeps the printed display, numeric value when parsed, unit, population context, source count, and every source identity, version/effective date or explicit absence, retrieval date, locator, safe link, and excerpt. |
Reader
Search and filter the rows
Showing 1,101–1,110 of 1,681 matching rows. Filters and search terms remain attached when you move between pages or open the API view.
Projected row 1101
- Medicine slug
- nitrofurantoin
- Compared field
- bioavailability
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 77
- Source count
- 58
- Agreement rate
- 1
- Recorded readings
40%
- Numeric value
- 40
- Unit
- %
- Source records
- 58
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 58 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fbc05ccb-782b-55f6-e053-6394a90a7fd6 (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When nitrofurantoin (monohydrate/macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:85c7d4ee-99f5-4324-a5fa-601c2fe664ab (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When nitrofurantoin capsule (monohydrate/macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:25172572-dbdc-db70-e063-6394a90aa87b (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When nitrofurantoin capsule (monohydrate/macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d802d734-dc8f-4f3c-bce6-aaccc4614c89 (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When nitrofurantoin (monohydrate/macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1ab658f0-021a-46a1-bff3-d3334c23442d (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When nitrofurantoin (monohydrate/macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:56e07ad3-7224-4aaf-9a68-0d48d4abfec8 (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When Nitrofurantoin Capsules, USP (monohydrate/ macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:34d3c103-27b8-454b-9f38-c33157c3b6fc (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When Nitrofurantoin Capsules, USP (monohydrate/ macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:39ffb8c6-4dd8-4436-b857-7306c15f662a (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When Nitrofurantoin Capsules, USP (monohydrate/ macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6bccbaab-151b-4a04-e053-2991aa0ae105 (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When nitrofurantoin (monohydrate/macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ee3f300a-d6d3-49c4-bd60-425f04d30b88 (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When nitrofurantoin capsule (monohydrate/macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1f7a9414-5592-f2ca-e063-6394a90a75f4 (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When nitrofurantoin capsule (monohydrate/macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d9840719-271f-42a9-a5c9-3e039ec8fbac (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When nitrofurantoin monohydrate/macrocrystals capsules are administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:05f4b126-0fb9-5ee9-c89c-f229e60f84e3 (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When nitrofurantoin (monohydrate/macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d88348a0-6ab4-4490-9325-1f14a541b0a5 (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When Nitrofurantoin Capsules, USP (monohydrate/ macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:09944470-807d-ad37-e063-6394a90a7bfe (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When Nitrofurantoin Capsules, USP (monohydrate/ macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6c82b95d-2c32-4e54-a8a9-a4bb4df70cb5 (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When Nitrofurantoin Capsules, USP (monohydrate/ macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:266824c7-7e9f-4c5f-b642-3bb7bf1c4fe6 (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When nitrofurantoin capsule (monohydrate/macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b807bd48-71ab-4578-b1d7-4d3260bf6c75 (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When Nitrofurantoin Capsules, USP (monohydrate/ macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8d2e456a-ffb2-3f1e-e053-2995a90a22df (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When nitrofurantoin monohydrate/macrocrystals capsules are administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1c5db054-58af-4932-8fad-c3883b13f987 (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When Nitrofurantoin Capsules, USP (monohydrate/ macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:11e8f91c-5712-4267-9956-e619d081d1f4 (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When nitrofurantoin capsule (monohydrate/macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:055477be-e42c-fe8b-e063-6394a90a0449 (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When nitrofurantoin capsule (monohydrate/macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ea28d766-d6e6-43d2-8282-dc78a0381057 (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When nitrofurantoin capsule (monohydrate/macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:729f6bbb-ab64-4b65-979a-4ad7605c5947 (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When Nitrofurantoin Capsules, USP (monohydrate/ macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f40af3e1-e54c-3a35-e053-2a95a90a6cb2 (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When Nitrofurantoin Capsules, USP (monohydrate/ macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e55f3dc2-c754-4550-a2c0-c304471a8791 (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When nitrofurantoin capsule (monohydrate/macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:75dab97e-59b4-447c-a8c9-b4d5a970098f (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When Nitrofurantoin Capsules, USP (monohydrate/ macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:643cdcff-8599-4326-b3ca-d9fd270e0fc2 (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When nitrofurantoin (monohydrate/macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:10e2503d-a250-996f-e063-6294a90abd61 (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When nitrofurantoin capsule (monohydrate/macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e47175a3-68a2-4084-9c0e-96fb057448bf (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When nitrofurantoin capsules (monohydrate/macrocrystals) are administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b6c5bbb0-86db-4a76-a1eb-98573a0b0adc (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When nitrofurantoin capsule (monohydrate/macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:155c8d68-576e-f85c-e063-6294a90ada4b (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When nitrofurantoin capsule (monohydrate/macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bebbe5d6-f6ec-4191-bad3-b6e933da0688 (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When Nitrofurantoin Capsules, USP (monohydrate/ macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:37606c6f-0d85-4314-94ae-f7732c7bc8d5 (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When Nitrofurantoin Capsules, USP (monohydrate/ macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8450fee6-7b9d-4c74-848e-c4f42c1963f9 (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When nitrofurantoin (monohydrate/macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:04b4189e-9b21-78ed-e063-6394a90ab8e0 (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When nitrofurantoin (monohydrate/macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f49f586a-79f0-4731-97f9-9aeb0839ece5 (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When nitrofurantoin capsule (monohydrate/macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:87210c87-b7db-0f65-e053-2a91aa0a4393 (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When nitrofurantoin (monohydrate/macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d1c778b5-70df-4312-976b-d0bca0cb602a (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When nitrofurantoin capsule (monohydrate/macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ae892973-9ef4-4cf0-baf3-fbe158697bac (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When nitrofurantoin (monohydrate/macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d4385368-46d6-8397-e053-2a95a90a8d68 (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When nitrofurantoin (monohydrate/macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d96098d0-3c2b-4e53-a3f0-3ebba81c4133 (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When nitrofurantoin capsule (monohydrate/macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:63a4b367-bf4b-4b5f-b3e9-394ba307886d (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When nitrofurantoin capsule (monohydrate/macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:68a651f9-1aef-792e-e053-2991aa0a3cbb (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When nitrofurantoin (monohydrate/macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0631d961-ef23-8f2a-e063-6294a90aa0a8 (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When nitrofurantoin (monohydrate/macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3dd034a6-8810-93f5-e063-6394a90a36c2 (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When nitrofurantoin capsule (monohydrate/macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7ba9a729-a73a-4a13-a336-0284cc8a67e1 (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When nitrofurantoin (monohydrate/macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:788f1fe3-d8a1-42cc-9280-07f842da34ea (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When nitrofurantoin (monohydrate/macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f4c2c01d-bef7-3e5d-e053-2995a90ae0d8 (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When Nitrofurantoin Capsules, USP (monohydrate/ macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7767697f-4dd0-477d-b5cc-e1ed5689f097 (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When nitrofurantoin (monohydrate/macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5087f071-5ef4-753e-e063-6294a90afb8d (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When nitrofurantoin capsule (monohydrate/macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b644426c-c8ba-4fe0-80c7-d9b2dde37395 (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When nitrofurantoin (monohydrate/macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2a772eb3-4fb3-4d92-b9f4-469dd2216361 (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When nitrofurantoin capsule (monohydrate/macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:18987b15-6554-6b55-e063-6294a90a58d4 (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When nitrofurantoin capsule (monohydrate/macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:35c0a6d8-ff85-4d9b-9ad3-ae20808119dd (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When nitrofurantoin capsule (monohydrate/macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:513b514f-6e79-f187-e063-6394a90a07dc (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When nitrofurantoin capsule (monohydrate/macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d1825b58-2c00-475d-8d9b-cc07c66383f5 (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When nitrofurantoin capsule (monohydrate/macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4553ccc1-0bad-4c75-aae2-1a1c87bc8db0 (opens source in a new tab)
Nitrofurantoin label
Version not recorded · Effective date not recorded
When nitrofurantoin capsule (monohydrate/macrocrystals) is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
Projected row 1102
- Medicine slug
- nitrofurantoin-macrocrystalline
- Compared field
- bioavailability
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 5
- Source count
- 5
- Agreement rate
- 1
- Recorded readings
40%
- Numeric value
- 40
- Unit
- %
- Source records
- 5
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 5 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8f270a9f-12a1-44d4-bc7e-873613555801 (opens source in a new tab)
Nitrofurantoin, Macrocrystalline label
Version not recorded · Effective date not recorded
When Macrobid is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:28bc9ec9-b8db-4ece-a14a-8bcf618cbf7e (opens source in a new tab)
Nitrofurantoin, Macrocrystalline label
Version not recorded · Effective date not recorded
When Macrobid is administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a4afd48b-003f-4ffa-9ca0-9432b8b0e22b (opens source in a new tab)
Nitrofurantoin, Macrocrystalline label
Version not recorded · Effective date not recorded
When nitrofurantoin capsules (monohydrate/macrocrystals) are administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:22061f76-2c05-4501-b8dd-a5c372abe7c2 (opens source in a new tab)
Nitrofurantoin, Macrocrystalline label
Version not recorded · Effective date not recorded
When nitrofurantoin monohydrate/macrocrystals capsules are administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1a86deef-0887-43b1-bb96-dbc222b15931 (opens source in a new tab)
Nitrofurantoin, Macrocrystalline label
Version not recorded · Effective date not recorded
When nitrofurantoin capsules (monohydrate/macrocrystals) are administered with food, the bioavailability of nitrofurantoin is increased by approximately 40%.
Projected row 1103
- Medicine slug
- nitroglycerin
- Compared field
- bioavailability
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 68
- Source count
- 42
- Agreement rate
- 0.833333
- Recorded readings
40%
- Numeric value
- 40
- Unit
- %
- Source records
- 35
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 35 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:26c314ea-077e-490b-826b-2aafcb6e9564 (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
The absolute bioavailability of nitroglycerin from nitroglycerin sublingual tablets is approximately 40% but tends to be variable due to factors influencing drug absorption, such as sublingual hydration and mucosal metabolism.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6671d89f-cc89-c03c-e053-2a91aa0aa5fa (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
The absolute bioavailability of nitroglycerin from nitroglycerin sublingual tablets is approximately 40% but tends to be variable due to factors influencing drug absorption, such as sublingual hydration and mucosal metabolism.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f9b52553-5a26-d374-e053-6294a90a40c7 (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
The absolute bioavailability of nitroglycerin from nitroglycerin sublingual tablets is approximately 40% but tends to be variable due to factors influencing drug absorption, such as sublingual hydration and mucosal metabolism.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:041f127e-5166-4484-bc1a-0a373d1187ae (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
The absolute bioavailability of nitroglycerin from nitroglycerin sublingual tablets is approximately 40% but tends to be variable due to factors influencing drug absorption, such as sublingual hydration and mucosal metabolism.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:38059df3-be1b-4226-9f12-c3c37cb44fea (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
The absolute bioavailability of nitroglycerin from nitroglycerin sublingual tablets is approximately 40% but tends to be variable due to factors influencing drug absorption, such as sublingual hydration and mucosal metabolism.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5a36dac2-7d35-4cbf-be3d-705b7135754d (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
The absolute bioavailability of nitroglycerin from nitroglycerin sublingual tablets is approximately 40% but tends to be variable due to factors influencing drug absorption, such as sublingual hydration and mucosal metabolism.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9a539019-5f43-1448-e053-2a95a90a3bca (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
The absolute bioavailability of nitroglycerin from nitroglycerin sublingual tablets is approximately 40% but tends to be variable due to factors influencing drug absorption, such as sublingual hydration and mucosal metabolism.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:532e30c4-cbda-4450-b0a0-e08601c202fb (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
The absolute bioavailability of nitroglycerin from nitroglycerin sublingual tablets is approximately 40% but tends to be variable due to factors influencing drug absorption, such as sublingual hydration and mucosal metabolism.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:61759752-dd07-4bed-8079-b578e3930519 (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
The absolute bioavailability of nitroglycerin from Nitroglycerin Sublingual Tablets is approximately 40% but tends to be variable due to factors influencing drug absorption, such as sublingual hydration and mucosal metabolism.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:160b85ac-d964-463b-9f1e-1429f14ed318 (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
The absolute bioavailability of nitroglycerin from nitroglycerin sublingual tablets is approximately 40% but tends to be variable due to factors influencing drug absorption, such as sublingual hydration and mucosal metabolism.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fc297c0a-a412-40be-8414-4bf9906fd300 (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
The absolute bioavailability of nitroglycerin from nitroglycerin sublingual tablets is approximately 40% but tends to be variable due to factors influencing drug absorption, such as sublingual hydration and mucosal metabolism.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f4ea9ad1-a71f-7cea-e053-2a95a90a106d (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
The absolute bioavailability of nitroglycerin from nitroglycerin sublingual tablets is approximately 40% but tends to be variable due to factors influencing drug absorption, such as sublingual hydration and mucosal metabolism.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fa789d65-9407-4965-bd06-4457444b42be (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
The absolute bioavailability of nitroglycerin from nitroglycerin sublingual tablets is approximately 40% but tends to be variable due to factors influencing drug absorption, such as sublingual hydration and mucosal metabolism.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3d71f76d-bb22-7251-e063-6394a90aa9d8 (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
The absolute bioavailability of nitroglycerin from nitroglycerin sublingual tablets is approximately 40% but tends to be variable due to factors influencing drug absorption, such as sublingual hydration and mucosal metabolism.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c20e89b4-57b5-259d-e053-2a95a90a0038 (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
The absolute bioavailability of nitroglycerin from nitroglycerin sublingual tablets is approximately 40% but tends to be variable due to factors influencing drug absorption, such as sublingual hydration and mucosal metabolism.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9a52da75-d0af-4237-96c0-0b12adfa8636 (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
The absolute bioavailability of nitroglycerin from NITROSTAT tablets is approximately 40% but tends to be variable due to factors influencing drug absorption, such as sublingual hydration and mucosal metabolism.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8959095a-8cd8-f7d4-e053-2995a90a6e8f (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
The absolute bioavailability of nitroglycerin from nitroglycerin sublingual tablets is approximately 40% but tends to be variable due to factors influencing drug absorption, such as sublingual hydration and mucosal metabolism.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:89da40c1-bab1-422e-b326-8ebcbdbc81f3 (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
The absolute bioavailability of nitroglycerin from nitroglycerin sublingual tablets is approximately 40% but tends to be variable due to factors influencing drug absorption, such as sublingual hydration and mucosal metabolism.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c555f8de-477f-0225-98a2-baf8945bbd63 (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
The absolute bioavailability of nitroglycerin from nitroglycerin sublingualtablets is approximately 40% but tends to be variable due to factors influencing drug absorption, such as sublingual hydration and mucosal metabolism.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:941ac242-120e-47c1-ac03-50026ff93dd6 (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
The absolute bioavailability of nitroglycerin from nitroglycerin sublingual tablets is approximately 40% but tends to be variable due to factors influencing drug absorption, such as sublingual hydration and mucosal metabolism.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3f7ebc5e-82a7-393d-e063-6394a90a173a (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
The absolute bioavailability of nitroglycerin from nitroglycerin sublingual tablets is approximately 40% but tends to be variable due to factors influencing drug absorption, such as sublingual hydration and mucosal metabolism.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3dd022d8-c224-d19f-e063-6394a90adca4 (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
The absolute bioavailability of nitroglycerin from nitroglycerin sublingual tablets is approximately 40% but tends to be variable due to factors influencing drug absorption, such as sublingual hydration and mucosal metabolism.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4e83a438-1ed6-0a86-e063-6294a90adc8c (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
The absolute bioavailability of nitroglycerin from nitroglycerin sublingual tablets is approximately 40% but tends to be variable due to factors influencing drug absorption, such as sublingual hydration and mucosal metabolism.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f7059ff7-bf74-48b4-811d-6eb1c26bfd8b (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
The absolute bioavailability of nitroglycerin from NITROSTAT tablets is approximately 40% but tends to be variable due to factors influencing drug absorption, such as sublingual hydration and mucosal metabolism.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:67a15ee9-a6ae-4a60-8333-e06c608cfd71 (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
The absolute bioavailability of nitroglycerin from nitroglycerin sublingual tablets is approximately 40% but tends to be variable due to factors influencing drug absorption, such as sublingual hydration and mucosal metabolism.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:df52ab34-e44c-46f3-8c44-2c1bcb93f28e (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
The absolute bioavailability of nitroglycerin from nitroglycerin sublingualtablets is approximately 40% but tends to be variable due to factors influencing drug absorption, such as sublingual hydration and mucosal metabolism.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:486f53ce-e3c6-48b0-a6ef-9d08cde387e3 (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
The absolute bioavailability of nitroglycerin from nitroglycerin sublingual tablets is approximately 40% but tends to be variable due to factors influencing drug absorption, such as sublingual hydration and mucosal metabolism.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:84739085-81df-4a43-8456-c9edfbf971e9 (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
The absolute bioavailability of nitroglycerin from nitroglycerin sublingual tablets is approximately 40% but tends to be variable due to factors influencing drug absorption, such as sublingual hydration and mucosal metabolism.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:141b6098-dd8e-4c99-a581-197d46f9e0b1 (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
The absolute bioavailability of nitroglycerin from nitroglycerin sublingual tablets is approximately 40% but tends to be variable due to factors influencing drug absorption, such as sublingual hydration and mucosal metabolism.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:594b939f-d399-835e-e063-6294a90a4422 (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
The absolute bioavailability of nitroglycerin from nitroglycerin sublingual tablets is approximately 40% but tends to be variable due to factors influencing drug absorption, such as sublingual hydration and mucosal metabolism.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4b4667e9-3b5e-4dc0-e063-6394a90ac1f5 (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
The absolute bioavailability of nitroglycerin from nitroglycerin sublingual tablets is approximately 40% but tends to be variable due to factors influencing drug absorption, such as sublingual hydration and mucosal metabolism.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2bad7976-4eb0-d064-e063-6394a90a75de (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
The absolute bioavailability of nitroglycerin from nitroglycerin sublingual tablets is approximately 40% but tends to be variable due to factors influencing drug absorption, such as sublingual hydration and mucosal metabolism.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:41fe1f25-bfd0-4eaf-973d-bdb6b5d70f93 (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
The absolute bioavailability of nitroglycerin from nitroglycerin sublingual tablets is approximately 40% but tends to be variable due to factors influencing drug absorption, such as sublingual hydration and mucosal metabolism.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6fe3965f-0dd8-4bae-9771-de25074cb1b0 (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
The absolute bioavailability of nitroglycerin from NITROSTAT tablets is approximately 40% but tends to be variable due to factors influencing drug absorption, such as sublingual hydration and mucosal metabolism.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5265648f-3062-48a2-a4e3-fea1207807a8 (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
The absolute bioavailability of nitroglycerin from NITROSTAT tablets is approximately 40% but tends to be variable due to factors influencing drug absorption, such as sublingual hydration and mucosal metabolism.
0.2%
- Numeric value
- 0.2
- Unit
- %
- Source records
- 7
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 7 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:603aa9ed-54c4-4a35-ade4-690fa44850e4 (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption: In six healthy subjects, the average absolute bioavailability of nitroglycerin applied to the anal canal as a 0.2% w/w ointment was approximately 50% of the 0.75 mg nitroglycerin dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:562d2e03-dfed-41ff-8e7f-ec4169141983 (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption: In six healthy subjects, the average absolute bioavailability of nitroglycerin applied to the anal canal as a 0.2% w/w ointment was approximately 50% of the 0.75 mg nitroglycerin dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7cf08521-aaf6-4129-9f8e-077d6282fbc6 (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption: In six healthy subjects, the average absolute bioavailability of nitroglycerin applied to the anal canal as a 0.2% w/w ointment was approximately 50% of the 0.75 mg nitroglycerin dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ac908e70-9425-4e9c-8c67-7b2882b40204 (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption: In six healthy subjects, the average absolute bioavailability of nitroglycerin applied to the anal canal as a 0.2% w/w ointment was approximately 50% of the 0.75 mg nitroglycerin dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7bcead76-a90f-4140-9c73-4339d981a084 (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption: In six healthy subjects, the average absolute bioavailability of nitroglycerin applied to the anal canal as a 0.2% w/w ointment was approximately 50% of the 0.75 mg nitroglycerin dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f0a76edb-9e63-4aa4-9362-7375c799b2b5 (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption: In six healthy subjects, the average absolute bioavailability of nitroglycerin applied to the anal canal as a 0.2% w/w ointment was approximately 50% of the 0.75 mg nitroglycerin dose.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:543ef8c8-d520-461b-bf6e-f8d8c277feec (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption: In six healthy subjects, the average absolute bioavailability of nitroglycerin applied to the anal canal as a 0.2% w/w ointment was approximately 50% of the 0.75 mg nitroglycerin dose.
Projected row 1104
- Medicine slug
- nitroglycerin
- Compared field
- volumeOfDistribution
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 68
- Source count
- 25
- Agreement rate
- 0.8
- Recorded readings
3 L/kg
- Numeric value
- 3
- Unit
- L/kg
- Source records
- 20
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 20 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:603aa9ed-54c4-4a35-ade4-690fa44850e4 (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
Distribution: The volume of distribution of nitroglycerin following intravenous administration is about 3 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b8af0974-33ea-4dd5-9ff7-3b61272aeb25 (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
Pharmacokinetics: The volume of distribution of nitroglycerin is about 3 L/kg, and nitroglycerin is cleared from this volume at extremely rapid rates, with a resulting serum half-life of about 3 minutes.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c17c997b-0e90-4105-888b-2de22d2bf697 (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
Pharmacokinetics: The volume of distribution of nitroglycerin is about 3 L/kg, and nitroglycerin is cleared from this volume at extremely rapid rates, with a resulting serum half-life of about three minutes.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5e15296c-5acd-4bcc-80a8-b49cb1ef3eb0 (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
Pharmacokinetics The volume of distribution of nitroglycerin is about 3 L/kg, and nitroglycerin is cleared from this volume at extremely rapid rates, with a resulting serum half-life of about 3 minutes.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:578d8159-5ec6-457f-b4a8-9add624d43a8 (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
Pharmacokinetics: The volume of distribution of nitroglycerin is about 3 L/kg, and nitroglycerin is cleared from this volume at extremely rapid rates, with a resulting serum half-life of about 3 minutes.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:457a026c-ebce-4701-9deb-2d7652759a99 (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
Pharmacokinetics: The volume of distribution of nitroglycerin is about 3 L/kg, and nitroglycerin is cleared from this volume at extremely rapid rates, with a resulting serum half-life of about 3 minutes.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4f85d2e0-2e37-fcd1-276d-5a6466554289 (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
Pharmacokinetics: The volume of distribution of nitroglycerin is about 3 L/kg, and nitroglycerin is cleared from this volume at extremely rapid rates, with a resulting serum half-life of about 3 minutes.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e98a2692-1cb9-4994-98d8-1d8d9ef1a256 (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
Pharmacokinetics The volume of distribution of nitroglycerin is about 3 L/kg, and nitroglycerin is cleared from this volume at extremely rapid rates, with a resulting serum half-life of about 3 minutes.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3f2c9570-a544-1982-e063-6294a90a3067 (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
Pharmacokinetics: The volume of distribution of nitroglycerin is about 3 L/kg, and nitroglycerin is cleared from this volume at extremely rapid rates, with a resulting serum half-life of about 3 minutes.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:562d2e03-dfed-41ff-8e7f-ec4169141983 (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
Distribution: The volume of distribution of nitroglycerin following intravenous administration is about 3 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7cf08521-aaf6-4129-9f8e-077d6282fbc6 (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
Distribution: The volume of distribution of nitroglycerin following intravenous administration is about 3 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ac908e70-9425-4e9c-8c67-7b2882b40204 (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
Distribution: The volume of distribution of nitroglycerin following intravenous administration is about 3 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7bcead76-a90f-4140-9c73-4339d981a084 (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
Distribution: The volume of distribution of nitroglycerin following intravenous administration is about 3 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f0a76edb-9e63-4aa4-9362-7375c799b2b5 (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
Distribution: The volume of distribution of nitroglycerin following intravenous administration is about 3 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7da79fdf-0969-1ddd-e053-2991aa0a3ec4 (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
Pharmacokinetics: The volume of distribution of nitroglycerin is about 3 L/kg, and nitroglycerin is cleared from this volume at extremely rapid rates, with a resulting serum half-life of about three minutes.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8c52cdf6-87be-4719-b105-f08be096d462 (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
Pharmacokinetics: The volume of distribution of nitroglycerin is about 3 L/kg, and nitroglycerin is cleared from this volume at extremely rapid rates, with a resulting serum half-life of about 3 minutes.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:543ef8c8-d520-461b-bf6e-f8d8c277feec (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
Distribution: The volume of distribution of nitroglycerin following intravenous administration is about 3 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9453bd8b-5d54-5dc8-e053-2995a90a95b2 (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
Pharmacokinetics: The volume of distribution of nitroglycerin is about 3 L/kg, and nitroglycerin is cleared from this volume at extremely rapid rates, with a resulting serum half-life of about 3 minutes.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3c11c1c2-8e62-4f63-8293-2f8b8d845f7e (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
Pharmacokinetics: The volume of distribution of nitroglycerin is about 3 L/kg, and nitroglycerin, is cleared from this volume at extremely rapid rates, with a resulting serum half-life of about 3 minutes.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e464e9bb-48e8-4b9f-9fff-e220cfbac0c5 (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
Pharmacokinetics: The volume of distribution of nitroglycerin is about 3 L/kg, and nitroglycerin is cleared from this volume at extremely rapid rates, with a resulting serum half-life of about three minutes.
3.3 L/kg
- Numeric value
- 3.3
- Unit
- L/kg
- Source records
- 5
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 5 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e7bbeff1-e4f1-43a6-a1b3-a8c3dcae817d (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
The volume of distribution of nitroglycerin following intravenous administration is 3.3 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fadd07b7-189b-4678-ad0f-bf1e4d3d1300 (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
The volume of distribution of nitroglycerin following intravenous administration is 3.3 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:422b4713-9531-f1bf-e063-6294a90ada2b (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
The volume of distribution of nitroglycerin following intravenous administration is 3.3 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d19b5f51-ca85-48d6-9ccd-8ae26249cdc3 (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
The volume of distribution of nitroglycerin following intravenous administration is 3.3 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f9731c86-34b0-42a2-8b39-eca907e02e74 (opens source in a new tab)
Nitroglycerin label
Version not recorded · Effective date not recorded
The volume of distribution of nitroglycerin following intravenous administration is 3.3 L/kg.
Projected row 1105
- Medicine slug
- nizatidine
- Compared field
- bioavailability
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 4
- Source count
- 4
- Agreement rate
- 1
- Recorded readings
70%
- Numeric value
- 70
- Unit
- %
- Source records
- 4
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 4 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:367a1004-59c1-4474-a4f6-ce8bf5a1b043 (opens source in a new tab)
Nizatidine label
Version not recorded · Effective date not recorded
Pharmacokinetics – The absolute oral bioavailability of nizatidine exceeds 70%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:faaa7cc4-fda9-d5b8-de2a-71c8744ccb76 (opens source in a new tab)
Nizatidine label
Version not recorded · Effective date not recorded
Pharmacokinetics The absolute oral bioavailability of nizatidine exceeds 70%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:39e62997-8781-449a-e054-00144ff88e88 (opens source in a new tab)
Nizatidine label
Version not recorded · Effective date not recorded
Pharmacokinetics —The absolute oral bioavailability of nizatidine exceeds 70%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e9957997-8b85-48a0-9bb3-b878cb223236 (opens source in a new tab)
Nizatidine label
Version not recorded · Effective date not recorded
Pharmacokinetics The absolute oral bioavailability of nizatidine exceeds 70%.
Projected row 1106
- Medicine slug
- nizatidine
- Compared field
- halfLife
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 4
- Source count
- 4
- Agreement rate
- 1
- Recorded readings
1 to 2 hours
- Numeric value
- 1
- Unit
- hours
- Source records
- 4
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 4 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:367a1004-59c1-4474-a4f6-ce8bf5a1b043 (opens source in a new tab)
Nizatidine label
Version not recorded · Effective date not recorded
The elimination half-life is 1 to 2 hours, plasma clearance is 40 to 60 L/h, and the volume of distribution is 0.8 to 1.5 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:faaa7cc4-fda9-d5b8-de2a-71c8744ccb76 (opens source in a new tab)
Nizatidine label
Version not recorded · Effective date not recorded
The elimination half-life is 1 to 2 hours, plasma clearance is 40 to 60 L/h, and the volume of distribution is 0.8 to 1.5 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:39e62997-8781-449a-e054-00144ff88e88 (opens source in a new tab)
Nizatidine label
Version not recorded · Effective date not recorded
The elimination half-life is 1 to 2 hours, plasma clearance is 40 to 60 L/h, and the volume of distribution is 0.8 to 1.5 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e9957997-8b85-48a0-9bb3-b878cb223236 (opens source in a new tab)
Nizatidine label
Version not recorded · Effective date not recorded
The elimination half-life is 1 to 2 hours, plasma clearance is 40 to 60 L/h, and the volume of distribution is 0.8 to 1.5 L/kg.
Projected row 1107
- Medicine slug
- nizatidine
- Compared field
- volumeOfDistribution
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 4
- Source count
- 4
- Agreement rate
- 1
- Recorded readings
0.8 to 1.5 L/kg
- Numeric value
- 0.8
- Unit
- L/kg
- Source records
- 4
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 4 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:367a1004-59c1-4474-a4f6-ce8bf5a1b043 (opens source in a new tab)
Nizatidine label
Version not recorded · Effective date not recorded
The elimination half-life is 1 to 2 hours, plasma clearance is 40 to 60 L/h, and the volume of distribution is 0.8 to 1.5 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:faaa7cc4-fda9-d5b8-de2a-71c8744ccb76 (opens source in a new tab)
Nizatidine label
Version not recorded · Effective date not recorded
The elimination half-life is 1 to 2 hours, plasma clearance is 40 to 60 L/h, and the volume of distribution is 0.8 to 1.5 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:39e62997-8781-449a-e054-00144ff88e88 (opens source in a new tab)
Nizatidine label
Version not recorded · Effective date not recorded
The elimination half-life is 1 to 2 hours, plasma clearance is 40 to 60 L/h, and the volume of distribution is 0.8 to 1.5 L/kg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e9957997-8b85-48a0-9bb3-b878cb223236 (opens source in a new tab)
Nizatidine label
Version not recorded · Effective date not recorded
The elimination half-life is 1 to 2 hours, plasma clearance is 40 to 60 L/h, and the volume of distribution is 0.8 to 1.5 L/kg.
Projected row 1108
- Medicine slug
- norepinephrine
- Compared field
- proteinBinding
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 35
- Source count
- 28
- Agreement rate
- 1
- Recorded readings
25%
- Numeric value
- 25
- Unit
- %
- Source records
- 28
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 28 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4408987e-690a-41ac-9677-e24604fa9793 (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
Distribution Plasma protein binding of norepinephrine is approximately 25%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2ffda6e7-d45d-4af3-a3b1-250a4c95e736 (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
Distribution Plasma protein binding of norepinephrine is approximately 25%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e6669ed6-9ebc-4b2d-9a8c-5e318fbd18b4 (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
Distribution Plasma protein binding of norepinephrine is approximately 25%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:53578ac5-b510-4698-a097-f785bfea9fc0 (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
Distribution Plasma protein binding of norepinephrine is approximately 25%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ddbef60d-c20a-4ada-928f-e87074c08a54 (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
Distribution Plasma protein binding of norepinephrine is approximately 25%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0ea48ab6-e166-df31-b132-70ef982a2d02 (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
Distribution Plasma protein binding of norepinephrine is approximately 25%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dec04acd-8e66-43c7-80b0-468802eba093 (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
Distribution Plasma protein binding of norepinephrine is approximately 25%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c297757e-35ff-4f39-bccd-61002ac51e23 (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
Distribution Plasma protein binding of norepinephrine is approximately 25%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4bb42f07-a41e-42f3-92e7-dab665584f84 (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
Distribution Plasma protein binding of norepinephrine is approximately 25%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c42d425a-094e-4390-b4f9-4bb4b0fbc7d0 (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
Distribution Plasma protein binding of norepinephrine is approximately 25%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fd398152-b428-4dca-8478-b691b909ee0e (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
Distribution Plasma protein binding of norepinephrine is approximately 25%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dfed53ef-2060-44b8-a62e-9f8ee10a05a5 (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
Distribution Plasma protein binding of norepinephrine is approximately 25%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:109aa5e6-4e42-4131-97b0-f24d3a4cb4e8 (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
Distribution Plasma protein binding of norepinephrine is approximately 25%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:52e22892-4fc3-4f53-9f39-0b5c66da3040 (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
Distribution Plasma protein binding of norepinephrine is approximately 25%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dd4b7827-2fe9-4427-a40a-60f275611bf4 (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
Distribution Plasma protein binding of norepinephrine is approximately 25%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cc9ecec5-3bd7-4132-9745-7666bac8ceac (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
Distribution Plasma protein binding of norepinephrine is approximately 25%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4b054c27-ed64-40e2-8eba-b7f2ec780a82 (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
Distribution Plasma protein binding of norepinephrine is approximately 25%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c90d875c-8e6e-284e-e053-2a95a90a334f (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
Distribution Plasma protein binding of norepinephrine is approximately 25%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e375a0b9-4d26-4749-bbc3-43d63a7cf65a (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
Distribution Plasma protein binding of norepinephrine is approximately 25%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:728734e7-1684-4b37-980c-f1dfd408b436 (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
Distribution Plasma protein binding of norepinephrine is approximately 25%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2c7dd2b0-cc10-4db6-bf56-6eb154ebeb10 (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
Distribution Plasma protein binding of norepinephrine is approximately 25%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6363e9b4-29df-4553-904d-a563e5adda6e (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
Distribution Plasma protein binding of norepinephrine is approximately 25%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7a4950ea-6369-4dd5-97be-df21a5a5055f (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
Distribution Plasma protein binding of norepinephrine is approximately 25%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c4de72a8-2a75-4984-ce90-e4870226dc12 (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
Distribution Plasma protein binding of norepinephrine is approximately 25%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:baba1002-8b62-4a24-a4e1-53e7a59c785a (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
Distribution Plasma protein binding of norepinephrine is approximately 25%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d3ea12e0-88cc-49b0-b06e-5199ecd6ca69 (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
Distribution Plasma protein binding of norepinephrine is approximately 25%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:39cda6c6-3857-4028-80cf-aef135f8c7e6 (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
Distribution Plasma protein binding of norepinephrine is approximately 25%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:759807dd-61a8-4f6f-8bf5-f6ee773c81bc (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
Distribution Plasma protein binding of norepinephrine is approximately 25%.
Projected row 1109
- Medicine slug
- norepinephrine
- Compared field
- volumeOfDistribution
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 35
- Source count
- 28
- Agreement rate
- 1
- Recorded readings
8.8 L
- Numeric value
- 8.8
- Unit
- L
- Source records
- 28
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 28 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4408987e-690a-41ac-9677-e24604fa9793 (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
The volume of distribution is 8.8 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2ffda6e7-d45d-4af3-a3b1-250a4c95e736 (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
The volume of distribution is 8.8 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e6669ed6-9ebc-4b2d-9a8c-5e318fbd18b4 (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
The volume of distribution is 8.8 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:53578ac5-b510-4698-a097-f785bfea9fc0 (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
The volume of distribution is 8.8 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ddbef60d-c20a-4ada-928f-e87074c08a54 (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
The volume of distribution is 8.8 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0ea48ab6-e166-df31-b132-70ef982a2d02 (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
The volume of distribution is 8.8 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dec04acd-8e66-43c7-80b0-468802eba093 (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
The volume of distribution is 8.8 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c297757e-35ff-4f39-bccd-61002ac51e23 (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
The volume of distribution is 8.8 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4bb42f07-a41e-42f3-92e7-dab665584f84 (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
The volume of distribution is 8.8 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c42d425a-094e-4390-b4f9-4bb4b0fbc7d0 (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
The volume of distribution is 8.8 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fd398152-b428-4dca-8478-b691b909ee0e (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
The volume of distribution is 8.8 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dfed53ef-2060-44b8-a62e-9f8ee10a05a5 (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
The volume of distribution is 8.8 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:109aa5e6-4e42-4131-97b0-f24d3a4cb4e8 (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
The volume of distribution is 8.8 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:52e22892-4fc3-4f53-9f39-0b5c66da3040 (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
The volume of distribution is 8.8 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dd4b7827-2fe9-4427-a40a-60f275611bf4 (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
The volume of distribution is 8.8 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cc9ecec5-3bd7-4132-9745-7666bac8ceac (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
The volume of distribution is 8.8 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4b054c27-ed64-40e2-8eba-b7f2ec780a82 (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
The volume of distribution is 8.8 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c90d875c-8e6e-284e-e053-2a95a90a334f (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
The volume of distribution is 8.8 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e375a0b9-4d26-4749-bbc3-43d63a7cf65a (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
The volume of distribution is 8.8 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:728734e7-1684-4b37-980c-f1dfd408b436 (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
The volume of distribution is 8.8 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2c7dd2b0-cc10-4db6-bf56-6eb154ebeb10 (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
The volume of distribution is 8.8 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6363e9b4-29df-4553-904d-a563e5adda6e (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
The volume of distribution is 8.8 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7a4950ea-6369-4dd5-97be-df21a5a5055f (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
The volume of distribution is 8.8 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c4de72a8-2a75-4984-ce90-e4870226dc12 (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
The volume of distribution is 8.8 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:baba1002-8b62-4a24-a4e1-53e7a59c785a (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
The volume of distribution is 8.8 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d3ea12e0-88cc-49b0-b06e-5199ecd6ca69 (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
The volume of distribution is 8.8 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:39cda6c6-3857-4028-80cf-aef135f8c7e6 (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
The volume of distribution is 8.8 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:759807dd-61a8-4f6f-8bf5-f6ee773c81bc (opens source in a new tab)
Norepinephrine label
Version not recorded · Effective date not recorded
The volume of distribution is 8.8 L.
Projected row 1110
- Medicine slug
- norethindrone
- Compared field
- bioavailability
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 30
- Source count
- 12
- Agreement rate
- 1
- Recorded readings
65%
- Numeric value
- 65
- Unit
- %
- Source records
- 12
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 12 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0b87cef0-610c-469d-92ba-4007f4bc3878 (opens source in a new tab)
Norethindrone label
Version not recorded · Effective date not recorded
Norethindrone appears to be completely absorbed following oral administration; however, it is subject to first pass metabolism resulting in an absolute bioavailability of approximately 65%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c9f00a3e-c827-4066-bf85-079b3a20f25e (opens source in a new tab)
Norethindrone label
Version not recorded · Effective date not recorded
Norethindrone appears to be completely absorbed following oral administration; however, it is subject to first pass metabolism resulting in an absolute bioavailability of approximately 65%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6e9f61a1-93ff-291a-bea8-9307a3b0378e (opens source in a new tab)
Norethindrone label
Version not recorded · Effective date not recorded
Norethindrone appears to be completely absorbed following oral administration; however, it is subject to first pass metabolism resulting in an absolute bioavailability of approximately 65%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:35b5ddb5-1729-4588-b2a2-ead56d78b6f9 (opens source in a new tab)
Norethindrone label
Version not recorded · Effective date not recorded
Norethindrone appears to be completely absorbed following oral administration; however, it is subject to first pass metabolism resulting in an absolute bioavailability of approximately 65%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:426ac898-7745-4645-bf9b-bae319e260e8 (opens source in a new tab)
Norethindrone label
Version not recorded · Effective date not recorded
Norethindrone appears to be completely absorbed following oral administration; however, it is subject to first pass metabolism resulting in an absolute bioavailability of approximately 65%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:af851d82-b30f-463b-9dba-0437225dc1ee (opens source in a new tab)
Norethindrone label
Version not recorded · Effective date not recorded
Norethindrone appears to be completely absorbed following oral administration; however, it is subject to first pass metabolism resulting in an absolute bioavailability of approximately 65%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bbd54f1e-2d48-4efa-a57e-7fa7b478c457 (opens source in a new tab)
Norethindrone label
Version not recorded · Effective date not recorded
Norethindrone appears to be completely absorbed following oral administration; however, it is subject to first pass metabolism resulting in an absolute bioavailability of approximately 65%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:59985565-af09-21ba-0336-3f6db7711bd1 (opens source in a new tab)
Norethindrone label
Version not recorded · Effective date not recorded
Norethindrone appears to be completely absorbed following oral administration; however, it is subject to first pass metabolism resulting in an absolute bioavailability of approximately 65%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:121fbf86-1d76-4579-be2f-be9a957b23ab (opens source in a new tab)
Norethindrone label
Version not recorded · Effective date not recorded
Norethindrone appears to be completely absorbed following oral administration; however, it is subject to first pass metabolism resulting in an absolute bioavailability of approximately 65%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:70231aa1-9dd2-420f-9cb3-432d3c2477d1 (opens source in a new tab)
Norethindrone label
Version not recorded · Effective date not recorded
Norethindrone appears to be completely absorbed following oral administration; however, it is subject to first pass metabolism resulting in an absolute bioavailability of approximately 65%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a786be85-49ba-4369-b510-7dccc10f7f18 (opens source in a new tab)
Norethindrone label
Version not recorded · Effective date not recorded
Norethindrone appears to be completely absorbed following oral administration; however, it is subject to first pass metabolism resulting in an absolute bioavailability of approximately 65%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8ec64ec8-fbc9-440d-9838-654a605d57da (opens source in a new tab)
Norethindrone label
Version not recorded · Effective date not recorded
Norethindrone appears to be completely absorbed following oral administration; however, it is subject to first pass metabolism resulting in an absolute bioavailability of approximately 65%.
Access
Query or download the projection
GET /api/datasets/source-consensus?limit=10&offset=1100Allowed query parameters
- q
- Case-insensitive text search over the public fields named for this dataset.
- state
- Exact comparability state.Values: agree, differ, not_comparable, insufficient_context
- field
- Exact recorded field key.Values: bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
- limit / offset
- Pagination is required. limit is at most 200; offset is bounded. Set format=csv for the same projected page as a download.
Reuse and corrections
Keep the boundary attached
CC BY 4.0 applies to RNAWiki licenses its selection, schema, structure, and derived projection. Quoted source passages and third-party records retain their original rights.
Cite RNAWiki, this dataset identifier, and the generated date. Keep the “does not mean” statement with any downstream display so a corpus measurement is not mistaken for medical advice.